| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired Hemophilia A After Nivolumab Therapy in a Patient With Metastatic Squamous Cell Carcinoma of the Lung Successfully Managed With Rituximab
|
Gokozan, Hamza N.
|
|
2019
|
20 |
5 |
p. e560-e563
|
artikel
|
| 2 |
Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non–small Cell Lung Cancer Recurrence
|
Lacour, Max
|
|
2019
|
20 |
5 |
p. 391-396
|
artikel
|
| 3 |
A Rare Fusion of CLIP1 and ALK in a Case of Non–Small-Cell Lung Cancer With Neuroendocrine Features
|
Pinsolle, Julian
|
|
2019
|
20 |
5 |
p. e535-e540
|
artikel
|
| 4 |
Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
|
Martin, Juliane
|
|
2019
|
20 |
5 |
p. 350-362.e4
|
artikel
|
| 5 |
Computed Tomography Imaging Characteristics of Non–Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis
|
Mendoza, Dexter P.
|
|
2019
|
20 |
5 |
p. 339-349
|
artikel
|
| 6 |
Durable Response After 2 Doses of Pembrolizumab in a Patient With Non–Small-Cell Lung Cancer With an Isolated Brain Metastasis
|
Uprety, Dipesh
|
|
2019
|
20 |
5 |
p. e552-e554
|
artikel
|
| 7 |
Early Detection of Recurrence in Patients With Locally Advanced Non–Small-Cell Lung Cancer via Circulating Tumor Cell Analysis
|
Chinniah, Chimbu
|
|
2019
|
20 |
5 |
p. 384-390.e2
|
artikel
|
| 8 |
Editorial Board
|
|
|
2019
|
20 |
5 |
p. A2
|
artikel
|
| 9 |
First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non–small-cell Lung Cancer: A Systematic Review and Network Meta-analysis
|
Kim, Ryul
|
|
2019
|
20 |
5 |
p. 331-338.e4
|
artikel
|
| 10 |
Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma
|
He, Zhen
|
|
2019
|
20 |
5 |
p. e548-e551
|
artikel
|
| 11 |
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort
|
Lau, Sally C.
|
|
2019
|
20 |
5 |
p. e576-e583
|
artikel
|
| 12 |
Patient-reported Outcomes After the Treatment of Early Stage Non–small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery
|
Alberts, Leonie
|
|
2019
|
20 |
5 |
p. 370-377.e3
|
artikel
|
| 13 |
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis
|
Téglási, Vanda
|
|
2019
|
20 |
5 |
p. 363-369.e2
|
artikel
|
| 14 |
Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer
|
Kamigaichi, Atsushi
|
|
2019
|
20 |
5 |
p. 397-403.e1
|
artikel
|
| 15 |
Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non–small-cell Lung Cancer
|
Sakakibara-Konishi, Jun
|
|
2019
|
20 |
5 |
p. e555-e559
|
artikel
|
| 16 |
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort
|
Brosseau, Solenn
|
|
2019
|
20 |
5 |
p. e564-e575
|
artikel
|
| 17 |
Table of Contents
|
|
|
2019
|
20 |
5 |
p. A3-A6
|
artikel
|
| 18 |
Thoracotomy and VATS Surgery in Local Non–Small-Cell Lung Cancer: Differences in Long-Term Health-Related Quality Of Life
|
Rauma, Ville
|
|
2019
|
20 |
5 |
p. 378-383
|
artikel
|
| 19 |
Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non–Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
|
Jiang, Yi
|
|
2019
|
20 |
5 |
p. e541-e547
|
artikel
|
| 20 |
Tumor Spread Through Air Spaces Is a Survival Predictor in Non–Small-Cell Lung Cancer
|
Wang, Shuai
|
|
2019
|
20 |
5 |
p. e584-e591
|
artikel
|
Tijdschrift beschrijving